Pharmacore

Pharmacore company information, Employees & Contact Information

Explore related pages

Related company profiles:

We’ve moved! For company news and updates follow Cambrex.

Company Details

Employees
92
Founded
-
Address
1 Meadowlands Plaza, East Rutherford,new Jersey 07073,united States
Phone
(336)841-5250
Email
in****@****ore.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
East Rutherford, New Jersey
Looking for a particular Pharmacore employee's phone or email?

Pharmacore Questions

News

Cambrex Commits $120 Million to Grow US API Manufacturing - Pharmaceutical Commerce

Cambrex Commits $120 Million to Grow US API Manufacturing Pharmaceutical Commerce

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply - Yahoo Finance

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply Yahoo Finance

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts - PR Newswire

Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts PR Newswire

Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA Submission - Nasdaq

Adial Pharmaceuticals Signs Agreements with Cambrex and Thermo Fisher for AD04 Drug Production and FDA Submission Nasdaq

Cambrex to Acquire Halo Pharma - CHEManager

Cambrex to Acquire Halo Pharma CHEManager

Permira seeks $4bn for sale of contract drugmaker Cambrex - Financial Times

Permira seeks $4bn for sale of contract drugmaker Cambrex Financial Times

Permira seeks $4 billion for sale of contract drugmaker Cambrex - PharmaLive

Permira seeks $4 billion for sale of contract drugmaker Cambrex PharmaLive

A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix | Organic Process Research & Development - ACS Publications

A Continuous Hydrogenation Reactor Based on a Powdered Catalyst Enmeshed in an Expanded Poly(tetrafluoroethylene) Matrix | Organic Process Research & Development ACS Publications

Permira targets $4bn Cambrex exit - Private Equity Wire

Permira targets $4bn Cambrex exit Private Equity Wire

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing - PR Newswire

Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing PR Newswire

Cambrex doubles liquid packaging capacity and weekly output at its Québec facility - News-Medical

Cambrex doubles liquid packaging capacity and weekly output at its Québec facility News-Medical

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash - GlobeNewswire

Cambrex to be Acquired by the Permira Funds for $60.00 per Share in Cash GlobeNewswire

Cambrex looks to fill 'onshore' API manufacturing demand with $50M expansion in Iowa - Fierce Pharma

Cambrex looks to fill 'onshore' API manufacturing demand with $50M expansion in Iowa Fierce Pharma

Cambrex completes $38 million expansion in North Carolina - Chemical & Engineering News

Cambrex completes $38 million expansion in North Carolina Chemical & Engineering News

Cambrex to pump $30M into expanding North Carolina manufacturing site - Fierce Pharma

Cambrex to pump $30M into expanding North Carolina manufacturing site Fierce Pharma

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific - PR Newswire

Cambrex Acquires Leading EU Stability Storage Company Q1 Scientific PR Newswire

Cambrex wraps up expansion of Snapdragon API plant in Massachusetts - Fierce Pharma

Cambrex wraps up expansion of Snapdragon API plant in Massachusetts Fierce Pharma

Technology Transfer and Process Development of Danicopan to Enable Process Validation - ACS Publications

Technology Transfer and Process Development of Danicopan to Enable Process Validation ACS Publications

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule - PR Newswire

Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule PR Newswire

Cambrex Announces Sale of Drug Product Business Unit - PR Newswire

Cambrex Announces Sale of Drug Product Business Unit PR Newswire

Snapdragon rebounds with a deal to be acquired by Cambrex - Chemical & Engineering News

Snapdragon rebounds with a deal to be acquired by Cambrex Chemical & Engineering News

Cambrex opening new high-potency API facility in U.S. - Fierce Pharma

Cambrex opening new high-potency API facility in U.S. Fierce Pharma

CDMO Cambrex flips its aggressive buyout script with $2B sale to Permira Funds - Fierce Pharma

CDMO Cambrex flips its aggressive buyout script with $2B sale to Permira Funds Fierce Pharma

Permira prepares $4bn Cambrex exit as contract drugmakers attract investors - Private Equity Insights

Permira prepares $4bn Cambrex exit as contract drugmakers attract investors Private Equity Insights

Cambrex adds continuous manufacturing to sites in U.S. and Europe - Fierce Pharma

Cambrex adds continuous manufacturing to sites in U.S. and Europe Fierce Pharma

Cambrex adds Avista Pharma to the fold in $250M deal - Fierce Pharma

Cambrex adds Avista Pharma to the fold in $250M deal Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma - Fierce Pharma

Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma Fierce Pharma

Permira Snaps Up Cambrex in Deal Valued at $2.4 Billion - BioSpace

Permira Snaps Up Cambrex in Deal Valued at $2.4 Billion BioSpace

Deal Roundup: Permira said to eye $4bn valuation through Cambrex sale, PAI agrees Marcolin exit to VSP Vision - AltAssets Private Equity News

Deal Roundup: Permira said to eye $4bn valuation through Cambrex sale, PAI agrees Marcolin exit to VSP Vision AltAssets Private Equity News

Cambrex buying Pharmacore in $25M deal - Fierce Pharma

Cambrex buying Pharmacore in $25M deal Fierce Pharma

Cambrex completes US$38 million capacity expansion in High Point, North Carolina - Indian Pharma Post

Cambrex completes US$38 million capacity expansion in High Point, North Carolina Indian Pharma Post

Cambrex Acquires Q1 Scientific in Waterford - businessplus.ie

Cambrex Acquires Q1 Scientific in Waterford businessplus.ie

Methods to Develop and Validate Bioassays - Genetic Engineering and Biotechnology News

Methods to Develop and Validate Bioassays Genetic Engineering and Biotechnology News

Lonza Makes Its Largest Acquisition: Cambrex’ Bio Businesses for $460M - Genetic Engineering and Biotechnology News

Lonza Makes Its Largest Acquisition: Cambrex’ Bio Businesses for $460M Genetic Engineering and Biotechnology News

Top Pharmacore Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant